bioRxivBioinformaticsPreprint
DALE-Eval: A comprehensive cell type-specific expression deconvolution benchmark for transcriptomics data
Abstract
Deconvolution of bulk transcriptomic data unlocks rich, cell type-specific insights from complex tissue samples. While cell type fraction deconvolution has been extensively developed and bench-marked, the next frontier--cell type-specific expression (CTSE) deconvolution--remains largely underexplored. Here, we introduce DALE-Eval, a comprehensive benchmark of CTSE methods, featuring novel evaluation metrics, identification of key drivers of performance, and practical recommendations for maximizing the value of CTSE in downstream applications.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CATD: A reproducible pipeline for selecting cell-type deconvolution methods across tissues
Anna Vathrakokoili Pournara, Zhichao Miao, … Irene Papatheodorou·Bioinformatics AdvancesPeer-reviewed·Jan 1, 2024
- HIDE: Hierarchical cell-type Deconvolution
Dennis Voelkl, Malte Mensching-Buhr, … Franziska Görtler·BioinformaticsPeer-reviewed·Jul 1, 2025
- Deconer: A comprehensive and systematic evaluation toolkit for reference-based cell type deconvolution algorithms using gene expression data
Wei Zhang, Xianglin Zhang, … Xiaowo Wang·bioRxiv·Dec 24, 2023
- Comprehensive benchmarking of computational deconvolution of transcriptomics data
Francisco Avila Cobos, José Alquicira-Hernández, … Katleen De Preter·bioRxiv·Jan 10, 2020
- Benchmarking cell-type deconvolution in cross-platform transcriptomic data
Aakanksha Singh, Pinar Cakmak, … Katharina Imkeller·Genome biologyPeer-reviewed·Aug 13, 2026
- Deconvolution of omics data in Python with Deconomix -- cellular compositions, cell-type specific gene regulation, and background contributions
Malte Mensching-Buhr, Thomas Sterr, … Michael Altenbuchinger·bioRxiv·Nov 28, 2024